Friday, April 14, 2017 1:26:48 AM
Future markets for vitiligo - view into the future of clinuvel as long as the admission studies are successful and market approval will get achieved. The figures are calculated by extrapolation of US-data (not based on country-specific data sources) ...
What do you think this will bring to us? Does it take still much longer now before afamelanotide is granted for Vitiligo now it's granted for EPP within the EU?
Clinuvel a safe investment.
Clinuvel isn't a start-up anymore, it's doing business. It's a grown-up Biotech company. Clinuvel undervalued.
Afamelanotide for EPP, granted in the EU. The only thing the FDA has to do is signing. The EMA did already the homework for them. What's keeping it up! There is absolutely no reason for that anymore.
It's better they fuse together.
Still $0,10 behind the australian closingprice yesterday and $0,25 behind UR9 at the Frankfurter borse! It's time America wakes up, the train is leaving.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM